Assenagon Asset Management S.A.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in REGN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$152,721,781
-$7,823,539 QoQ
Shares Held
244,927
+17.9% QoQ
Ownership
0.234%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1
of 40 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. REGN ranks #3 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $152,721,781 | 244,927 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $160,545,320 | 207,788 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $180,024,011 | 233,231 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $268,658,228 | 477,810 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $222,245,625 | 423,325 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $305,311,345 | 481,389 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $126,512,657 | 177,604 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $181,716,295 | 172,859 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $134,954,354 | 128,402 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $182,569,915 | 189,685 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $190,169,985 | 216,523 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $77,703,883 | 94,420 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $84,992,503 | 118,285 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $167,018,395 | 203,267 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $88,047,753 | 122,036 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $57,156,232 | 82,971 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $41,530,429 | 70,256 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $45,761,176 | 65,521 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $19,083,271 | 30,218 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $24,447,456 | 40,397 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $5,072,660 | 9,082 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $90,691,948 | 191,681 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $75,486,903 | 156,252 | Shares | Sole | 2021-02-01 | |
| 2020-06-30 | $21,620,698 | 34,668 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $614,757 | 1,259 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||